OBJECTIVE: Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia. METHODS: The 49 subjects (age range: 51-85 years) included 20 with and 29 without APOE-epsilon4. Baseline and follow-up neuropsychological assessments determined the degree of cognitive decline. RESULTS: Baseline mild depressive symptoms were greater in APOE-epsilon4 carriers than in non-carriers. The subject groups demonstrated significant cognitive decline at follow-up. APOE-epsilon4 carriers showed a significantly greater rate of verbal memory decline than non-carriers. Baseline depressive symptoms, however, did not predict future cognitive decline. CONCLUSIONS: These results suggest that APOE-epsilon4 carriers may have a greater severity of depressive symptoms than non-carriers. The APOE-epsilon4 allele (but not baseline mild depressive symptoms) is associated with verbal memory decline in middle-aged and older persons. Because of the limited range of depression scores in our sample, these findings should be interpreted with caution and not be generalized to patients with syndromal depression.
OBJECTIVE: Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia. METHODS: The 49 subjects (age range: 51-85 years) included 20 with and 29 without APOE-epsilon4. Baseline and follow-up neuropsychological assessments determined the degree of cognitive decline. RESULTS: Baseline mild depressive symptoms were greater in APOE-epsilon4 carriers than in non-carriers. The subject groups demonstrated significant cognitive decline at follow-up. APOE-epsilon4 carriers showed a significantly greater rate of verbal memory decline than non-carriers. Baseline depressive symptoms, however, did not predict future cognitive decline. CONCLUSIONS: These results suggest that APOE-epsilon4 carriers may have a greater severity of depressive symptoms than non-carriers. The APOE-epsilon4 allele (but not baseline mild depressive symptoms) is associated with verbal memory decline in middle-aged and older persons. Because of the limited range of depression scores in our sample, these findings should be interpreted with caution and not be generalized to patients with syndromal depression.
Authors: A Collie; P Maruff; R Shafiq-Antonacci; M Smith; M Hallup; P R Schofield; C L Masters; J Currie Journal: Neurology Date: 2001-06-12 Impact factor: 9.910
Authors: A S Rigaud; L Traykov; L Caputo; J Coste; F Latour; R Couderc; F Moulin; F Boller; F Forette Journal: Neuroepidemiology Date: 2001-10 Impact factor: 3.282
Authors: G W Small; S T Chen; S Komo; L Ercoli; K Miller; P Siddarth; A Kaplan; D Dorsey; H Lavretsky; S Saxena; S Y Bookheimer Journal: Int J Geriatr Psychiatry Date: 2001-11 Impact factor: 3.485
Authors: P Zill; R Engel; H Hampel; S Behrens; K Bürger; F Padberg; S Stübner; H J Möller; M Ackenheil; B Bondy Journal: Eur Arch Psychiatry Clin Neurosci Date: 2001 Impact factor: 5.270
Authors: M Mauricio; R O'Hara; J A Yesavage; L Friedman; H C Kraemer; M Van De Water; G M Murphy Journal: Am J Geriatr Psychiatry Date: 2000 Impact factor: 4.105
Authors: R J Caselli; D Osborne; E M Reiman; J G Hentz; C J Barbieri; A M Saunders; J Hardy; N R Graff-Radford; G R Hall; G E Alexander Journal: J Neurol Sci Date: 2001-08-15 Impact factor: 3.181
Authors: Helen Lavretsky; Prabha Siddarth; Vladimir Kepe; Linda M Ercoli; Karen J Miller; Alison C Burggren; Susan Y Bookheimer; Sung-Cheng Huang; Jorge R Barrio; Gary W Small Journal: Am J Geriatr Psychiatry Date: 2009-06 Impact factor: 4.105
Authors: Michael A Slifer; Eden R Martin; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance Journal: Neurosci Lett Date: 2009-03-06 Impact factor: 3.046
Authors: Elizabeth A Corsentino; Kathryn Sawyer; Natalie Sachs-Ericsson; Dan G Blazer Journal: Am J Geriatr Psychiatry Date: 2009-02 Impact factor: 4.105
Authors: Warren D Taylor; Brian Boyd; Rachel Turner; Douglas R McQuoid; Allison Ashley-Koch; James R MacFall; Ayman Saleh; Guy G Potter Journal: Brain Imaging Behav Date: 2017-02 Impact factor: 3.978